These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 32303824)

  • 21. Repigmentation through Melanocyte Regeneration in Vitiligo.
    Birlea SA; Goldstein NB; Norris DA
    Dermatol Clin; 2017 Apr; 35(2):205-218. PubMed ID: 28317529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of vitiligo with narrowband-UVB (TL01) combined with tacrolimus ointment (0.1%) vs. placebo ointment, a randomized right/left double-blind comparative study.
    Nordal EJ; Guleng GE; Rönnevig JR
    J Eur Acad Dermatol Venereol; 2011 Dec; 25(12):1440-3. PubMed ID: 21466589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.
    Asawanonda P; Klahan SO
    Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of combined treatment with NB-UVB and topical tacrolimus versus NB-UVB alone in patients with vitiligo vulgaris: a randomized intra-individual open comparative trial.
    Satyanarayan HS; Kanwar AJ; Parsad D; Vinay K
    Indian J Dermatol Venereol Leprol; 2013; 79(4):525-7. PubMed ID: 23760325
    [No Abstract]   [Full Text] [Related]  

  • 25. Repigmentation of Human Vitiligo Skin by NBUVB Is Controlled by Transcription of GLI1 and Activation of the β-Catenin Pathway in the Hair Follicle Bulge Stem Cells.
    Goldstein NB; Koster MI; Jones KL; Gao B; Hoaglin LG; Robinson SE; Wright MJ; Birlea SI; Luman A; Lambert KA; Shellman YG; Fujita M; Robinson WA; Roop DR; Norris DA; Birlea SA
    J Invest Dermatol; 2018 Mar; 138(3):657-668. PubMed ID: 29054607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo.
    Kullavanijaya P; Lim HW
    Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):248-51. PubMed ID: 15379875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo.
    Bakis-Petsoglou S; Le Guay JL; Wittal R
    Br J Dermatol; 2009 Oct; 161(4):910-7. PubMed ID: 19523170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment outcome and persistence of repigmentation from narrow-band ultraviolet B phototherapy in vitiligo.
    Silpa-Archa N; Weerasubpong P; Junsuwan N; Yothachai P; Supapueng O; Wongpraparut C
    J Dermatolog Treat; 2019 Nov; 30(7):691-696. PubMed ID: 30474443
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of NB-UVB combination therapy regimens for vitiligo: A systematic review and network meta-analysis.
    Zhu B; Liu C; Zhang L; Wang J; Chen M; Wei Y
    J Cosmet Dermatol; 2023 Mar; 22(3):1083-1098. PubMed ID: 36456176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of efficacy of narrow band UVB therapies with UVB alone, in combination with calcipotriol, and with betamethasone and calcipotriol in vitiligo.
    Akdeniz N; Yavuz IH; Gunes Bilgili S; Ozaydın Yavuz G; Calka O
    J Dermatolog Treat; 2014 Jun; 25(3):196-9. PubMed ID: 23441902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NB-UVB plus oral Polypodium leucotomos extract display higher efficacy than NB-UVB alone in patients with vitiligo.
    Pacifico A; Damiani G; Iacovelli P; Conic RRZ; ; Gonzalez S; Morrone A
    Dermatol Ther; 2021 Mar; 34(2):e14776. PubMed ID: 33433041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
    Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of microneedling combined with tacrolimus versus either one alone for vitiligo treatment.
    Ebrahim HM; Albalate W
    J Cosmet Dermatol; 2020 Apr; 19(4):855-862. PubMed ID: 32030880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of a preceding fractional carbon dioxide laser on the outcome of combined local narrowband ultraviolet B and topical steroids in patients with vitiligo in difficult-to-treat areas.
    Vachiramon V; Chaiyabutr C; Rattanaumpawan P; Kanokrungsee S
    Lasers Surg Med; 2016 Feb; 48(2):197-202. PubMed ID: 26175036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized controlled study of the effects of different modalities of narrow-band ultraviolet B therapy on the outcome of cultured autologous melanocytes transplantation in treating vitiligo.
    Zhang DM; Hong WS; Fu LF; Wei XD; Xu AE
    Dermatol Surg; 2014 Apr; 40(4):420-6. PubMed ID: 24446755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo.
    Lan CC; Chen GS; Chiou MH; Wu CS; Chang CH; Yu HS
    Br J Dermatol; 2005 Sep; 153(3):498-505. PubMed ID: 16120133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined therapy for resistant vitiligo lesions: NB-UVB, microneedling, and topical latanoprost, showed no enhanced efficacy compared to topical latanoprost and NB-UVB.
    Stanimirovic A; Kovacevic M; Korobko I; Šitum M; Lotti T
    Dermatol Ther; 2016 Sep; 29(5):312-316. PubMed ID: 27356486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of platelet-rich plasma on the outcome of short-term narrowband-ultraviolet B phototherapy in the treatment of vitiligo: a pilot study.
    Ibrahim ZA; El-Ashmawy AA; El-Tatawy RA; Sallam FA
    J Cosmet Dermatol; 2016 Jun; 15(2):108-16. PubMed ID: 26695436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of topical piperine combined with narrowband UVB on vitiligo treatment: A clinical trial study.
    Shafiee A; Hoormand M; Shahidi-Dadras M; Abadi A
    Phytother Res; 2018 Sep; 32(9):1812-1817. PubMed ID: 29781089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo: results of the HI-Light Vitiligo Trial.
    Thomas KS; Batchelor JM; Akram P; Chalmers JR; Haines RH; Meakin GD; Duley L; Ravenscroft JC; Rogers A; Sach TH; Santer M; Tan W; White J; Whitton ME; Williams HC; Cheung ST; Hamad H; Wright A; Ingram JR; Levell NJ; Goulding JMR; Makrygeorgou A; Bewley A; Ogboli M; Stainforth J; Ferguson A; Laguda B; Wahie S; Ellis R; Azad J; Rajasekaran A; Eleftheriadou V; Montgomery AA;
    Br J Dermatol; 2021 May; 184(5):828-839. PubMed ID: 33006767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.